Amy Jensen SmithSenior Director, Head of Discovery at SOTIO Biotech Inc., USA
Amy Jensen-Smith is the Senior Director, Head of Discovery Research at SOTIO where she and her team are committed to developing transformative next-gen CAR T therapies for patients with solid tumors. Prior to joining Sotio, Amy was responsible for building and leading target ID and validation and early drug discovery teams at bluebird bio and served as project lead for several CAR and TCR pipeline assets. Amy received her Ph.D. in immunology from Dartmouth Medical School in 2010. She performed post-doctoral research at the NCI under Steve Rosenberg and also completed an industry training postdoc at Novartis Institute for Biomedical Research.